These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8099190

  • 1. DNA analysis of head and neck squamous cell carcinoma by flow cytometry.
    Lampe HB.
    Laryngoscope; 1993 Jun; 103(6):637-44. PubMed ID: 8099190
    [Abstract] [Full Text] [Related]

  • 2. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F, Hiroi M, Yamane T, Hara H.
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [Abstract] [Full Text] [Related]

  • 3. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
    Hass HG, Schmidt A, Nehls O, Kaiser S.
    Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
    [Abstract] [Full Text] [Related]

  • 4. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A, Masetti R, Breccia C, Coppola R, Magistrelli P, Nuzzo G, Maggiano N, Picciocchi A.
    Hepatogastroenterology; 1999 Jan; 46(26):1187-91. PubMed ID: 10370689
    [Abstract] [Full Text] [Related]

  • 5. Measurement of proliferative index in squamous cell carcinoma by flow cytometry.
    Ferguson PJ, Garland A, Lampe HB.
    J Otolaryngol; 1992 Oct; 21(5):331-8. PubMed ID: 1361586
    [Abstract] [Full Text] [Related]

  • 6. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
    Goukon Y, Sasano H, Nishihira T, Nagura H, Mori S.
    Anticancer Res; 1994 Oct; 14(3B):1305-12. PubMed ID: 7915093
    [Abstract] [Full Text] [Related]

  • 7. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ, Parasi AS, Manioudaki HS, Laoutaris NP, Legakis NC, Peros GT, Androulakis GA.
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [Abstract] [Full Text] [Related]

  • 8. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry.
    Krauss JS, Pantazis CG, Chandler FW.
    Ann Clin Lab Sci; 1992 Apr; 22(3):189-96. PubMed ID: 1354428
    [Abstract] [Full Text] [Related]

  • 9. [Flow cytometry in ORL cancers].
    Michels JJ, Rame JP, de Raucourt D, Marnay J, Duigou F, Macé-Lesec'h J, Henry-Amar M, Mandard AM.
    Bull Cancer; 1997 Jul; 84(7):693-8. PubMed ID: 9339194
    [Abstract] [Full Text] [Related]

  • 10. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
    Margarino G, Scala M, Schenone G, Mereu P, Corvo R, Sanguineti G, Giaretti W, Geido E, Orecchia R, Meszaros P.
    Acta Otorhinolaryngol Ital; 1992 Jul; 12(5):421-33. PubMed ID: 1303006
    [Abstract] [Full Text] [Related]

  • 11. Clinical applications of DNA content parameters in patients with squamous cell carcinomas of the head and neck.
    Ensley JF, Maciorowski Z.
    Semin Oncol; 1994 Jun; 21(3):330-9. PubMed ID: 8209264
    [No Abstract] [Full Text] [Related]

  • 12. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
    Morita K, Hayashi Y, Nagao S, Watanabe Y.
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782
    [Abstract] [Full Text] [Related]

  • 13. [Results of impulse cytophotometry in malignant tumors of the head and neck. A prognostic parameter?].
    Brauneis JW, Laskawi R, Schröder M, Göhde W.
    HNO; 1989 Sep; 37(9):369-72. PubMed ID: 2808011
    [Abstract] [Full Text] [Related]

  • 14. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms.
    Teague K, el-Naggar A.
    Cytometry; 1994 Jan 01; 15(1):21-7. PubMed ID: 7909288
    [Abstract] [Full Text] [Related]

  • 15. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
    Nordström B, Strang P, Bergström R, Nilsson S, Tribukait B.
    Cancer; 1996 Nov 01; 78(9):1942-51. PubMed ID: 8909315
    [Abstract] [Full Text] [Related]

  • 16. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors.
    Wang LS, Chow KC, Chi KH, Liu CC, Li WY, Chiu JH, Huang MH.
    Am J Gastroenterol; 1999 Jul 01; 94(7):1933-40. PubMed ID: 10406262
    [Abstract] [Full Text] [Related]

  • 17. DNA ploidy in nonmelanoma skin cancer.
    Robinson JK, Rademaker AW, Goolsby C, Traczyk TN, Zoladz C.
    Cancer; 1996 Jan 15; 77(2):284-91. PubMed ID: 8625236
    [Abstract] [Full Text] [Related]

  • 18. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T, Kaneko S, Akazawa K, Tateishi M, Sugio K, Sugimachi K.
    Cancer Res; 1993 Oct 15; 53(20):5000-3. PubMed ID: 8104690
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Proliferating cell nuclear antigen in archival surgical specimens of malignant lymphoma and metastatic carcinoma: immunohistochemical and flow cytometric analysis.
    Gorczyca W, Kram A, Tuziak T, Darzynkiewicz Z, Melamed MR.
    Patol Pol; 1993 Oct 15; 44(3):121-8. PubMed ID: 7902557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.